While the tumor suppressive function of the activin signaling pathway is considered to be executed in a canonical Smad-dependent manner, the tumor promoting role of activin signaling in pancreatic cancer may be via the non-Smad-dependent pathways such as MAPK/JNK and PI3K/AKT [62] (Figure 1). This evidence concerns the gene INHBE and familial pancreatic carcinoma.